Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11528 posts found.

NICE shoots down Keytruda in head and neck cancer over data concerns

January 16, 2020 Sales and Marketing Cancer, NHS, NICE, UK, keytruda, pharma

It has been revealed that NICE has chosen to reject MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) for routine use on the …
News
shutterstock_512649

MorphoSys and Incyte forge potential $1.1bn partnership to develop B cell malignancy drug candidate

January 14, 2020 Manufacturing and Production, Sales and Marketing Incyte, morphosys, pharma, tafasitamab

MorphoSys and Incyte have joined together in a partnership to develop and commercialise the latter’s anti-CD19 antibody tafasitamab as a …
News
biogen_austria_238

Biogen picks up Pfizer’s Phase 1 therapy for Alzheimer’s symptoms in potential $700m deal

January 14, 2020 Manufacturing and Production, Sales and Marketing Alzheimer's, Biogen, Pfizer, pharma

Biogen has entered into an agreement with Pfizer to acquire the latter’s Phase 1 candidate PF-05251749 in order to develop …
News
zytiga_outside

NHS Scotland recommends Janssen’s Zytiga combo for newly diagnosed prostate cancer

January 13, 2020 Sales and Marketing Cancer, NHS, Scotland, nhs scotland, prostate cancer

Janssen’s Zytiga (abiraterone acetate) has just been approved by the Scottish Medicines Consortium (SMC), meaning that male patients on the …
News
jp-kress_mor

Working Life Interview: Jean-Paul Kress, CEO of MorphoSys

January 13, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Working Life, feature, morphosys, pharma

With a medical doctorate as well as degrees in pharmacology and immunology under your belt, was your path always to …
Feature

FDA approves Astellas injectable antifungal drug for newborns

January 13, 2020 Sales and Marketing Astellas, Atellas Pharma, FDA, fungal virsus

The FDA has approved the first antifungal drug to specifically treat invasive candidiasis in newborns. From Astellas, the new drug …
News
shutterstock_273326141

Eli Lilly to boost immunology portfolio with $1.1bn Dermira acquisition

January 13, 2020 Sales and Marketing Dermira, Eli Lilly, pharma

Eli Lilly has announced it has entered into an agreement to acquire Dermira, a biopharmaceutical firm focused on the development …
News
flag-1267780_1280

Pakistan registers cases against 200 pharmaceutical companies

January 13, 2020 Sales and Marketing National Task Force, Pakistan, Pakistani Pharmaceuticals, corruption

The Punjab Quality Control Board has sent at least 74 cases to the drugs courts for prosecution, and has overall …
News

AstraZeneca to discontinue trial for heart disease drug Epanova

January 13, 2020 Sales and Marketing AstraZeneca, Phase II Trial, Phase III trial, heart disease, triglycerides

AstraZeneca expects a $100 million writedown for its heart disease drug Epanova, as it discontinues its late stage trial. This …
News

Sanofi secures expanded European approval for Toujeo in type 1 diabetes

January 10, 2020 Medical Communications, Sales and Marketing EU, Sanofi, pharma, toujeo

Sanofi has revealed that the European Commission has expanded the existing label for Toujeo (insulin glargine 300 units/mL) to include …
News

US approval for Blueprint Medicines’ gastrointestinal stromal tumour therapy

January 10, 2020 Medical Communications, Sales and Marketing Ayvakit, Blueprint Medicines, Cancer, pharma

The FDA has moved to authorise Blueprint Medicines’ kinase inhibitor Ayvakit (avapritinib) for the treatment of unresectable or metastatic gastrointestinal …
News
4420456374_64a3d7e6aa_88

Top Ten most popular articles on Pharmafile.com this week

January 10, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The US pharamaceutical industry dominates the news this week, with Pfizer, Sanofi and GlaxoSmithKline all increasing their drug prices while …
News
merck-keytruda

MSD’s Keytruda chalks up bladder cancer approval in the US

January 9, 2020 Sales and Marketing Cancer, MSD, bladder cancer, keytruda, pharma

MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) has added another US approval to its repertoire with the news that FDA has awarded …
News
nmpa_logo

China approves first homegrown HPV vaccine

January 8, 2020 Research and Development, Sales and Marketing China, HPV, NMPA, pharma, vaccines

Female patients in China between the ages of nine and 45 will have access to the country’s first domestically-produced vaccine …
News
rami-levin-picture-3-002

Saniona appoints Rami Levin as President and Chief Executive Officer

January 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, rare diseases

Saniona has announced that Rami Levin will take over as the Chief Executive Officer of the company as it seeks …
Appointment
The Gateway to Local Adoption Series

Latest content

NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma

October 8, 2026

AstraZeneca’s Trixeo approved in EU for asthma

October 8, 2026

Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis

October 7, 2026

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial

October 6, 2026

ESTEVE CDMO adds $17.5m to Illinois expansion

October 6, 2026